ASB-XIV Cells
USD$800.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | ASB-xIV cells, originating from a female Balb/c mouse, closely mimic large cell carcinoma that has been induced by chrysotile asbestos in mouse lung cells. These cells are monolayer adherent with an epithelial morphology, positioning them as an exemplary model for primary squamous cell carcinoma (PSCC) research. Their structural and functional characteristics make them particularly suitable for detailed studies on the cellular processes and pathological mechanisms underlying PSCC. The ASB-xIV cell line is characterized as an "inflamed" or "hot" tumor, indicating a high degree of immune cell infiltration which makes it more responsive to immunotherapy. This sensitivity is pivotal in using ASB-xIV cells to evaluate the efficacy of immune checkpoint therapies (ICT). These cells have shown significant responsiveness to such treatments, making them invaluable in oncological research focused on immunotherapeutic efficacy. Additionally, while retinoids have been effective in curbing the growth of these cells in transplanted carcinomas in mice, vitamin C has failed to produce a similar effect. Despite their slow doubling time of approximately 70 hours, ASB-xIV cells maintain robust and stable growth, which is crucial for establishing consistent and reliable in vitro cultures necessary for experimental reproducibility. |
|---|---|
| Organism | Mouse |
| Tissue | Lung |
| Disease | Pulmonary squamous cell carcinoma |
Characteristics
| Age | Adult |
|---|---|
| Gender | Unspecified |
| Morphology | Epithelial-like |
| Growth properties | Adherent |
Regulatory Data
| Citation | ASB-xIV (Cytion catalog number 400120) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 10090 |
| CellosaurusAccession | CVCL_5686 |
Biomolecular Data
| Tumorigenic | Yes, in Balb/c mouse |
|---|---|
| Viruses | MAP-test: Negative (Sendai, Ektromelie, Polyoma, K-Virus, Kilham, Reo 3, PVM, LCM, M.pulmonis, MVM, Theiler's GD VII, Toolan's H-1, MHV, LDV, RCV/SDA, M-Adenovirus, B.piliformis). |
Handling
| Culture Medium | DMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 3.7 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS |
| Dissociation Reagent | Accutase |
| Doubling time | 70 hours |
| Subculturing | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Seeding density | A seeding density of 1 x 104 cells/cm2 is recommended. |
| Fluid renewal | Every 3 to 5 days |
| Post-Thaw Recovery | Allow the cells to adhere for at least 24 to 48 hours. |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Flask Coating | None |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 400120-030625 | Certificate of Analysis | 21. Jul. 2025 | 400120 |
| 400120-719 | Certificate of Analysis | 23. May. 2025 | 400120 |